Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$475K Buy
73,589
+59,486
+422% +$394K ﹤0.01% 1420
2026
Q1
$87.2K Buy
14,103
+3,855
+38% +$23.8K ﹤0.01% 1807
2025
Q4
$68.9K Sell
10,248
-9,678
-49% -$72.6K ﹤0.01% 1791
2025
Q3
$163K Sell
19,926
-4,291
-18% -$32.1K ﹤0.01% 1715
2025
Q2
$170K Buy
24,217
+5,539
+30% +$37.2K ﹤0.01% 1645
2025
Q1
$133K Buy
18,678
+8,374
+81% +$79K ﹤0.01% 1440
2024
Q4
$94.5K Buy
+10,304
New +$96.4K ﹤0.01% 1269

Other funds holding INGN

IEQ Capital's INGN Position: Q2 2026 in Review

IEQ Capital increased its Inogen (INGN) stake by 422% in Q2 2026, buying an estimated $394K and bringing the position to 73,589 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #1420.

IEQ Capital first reported a position in INGN in Q4 2024 and has held it in 7 quarters since. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • IEQ Capital held 73,589 shares of Inogen worth $475K as of Q2 2026.
  • IEQ Capital bought 59,486 Inogen shares in Q2 2026, an estimated $394K.
  • Inogen made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1420 holding.
  • IEQ Capital first reported a position in Inogen in Q4 2024 and has held it in 7 quarters since.
  • 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.